Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning.
Disease Suppression Persists With Ozanimod at 72 Weeks in MS
Right Under Our Noses: Olfactory Pathology In Central Nervous System Demyelinating Diseases
Ongoing Oxidative Stress Causes Subclinical Neuronal Dysfunction in the Recovery Phase of EAE.
Newly diagnosed multiple sclerosis in state of Qatar.
Including known covariates can reduce power to detect genetic effects in case-control studies.
Short and long term variation in ultraviolet radiation and multiple sclerosis.
Do not treat from CIS onset: evaluate disease course and prognosis first - No (treat!).
Parallel states of pathological Wnt signaling in neonatal brain injury and colon cancer.
Early Treatment with Anti-VLA-4 mAb Can Prevent the Infiltration and/or Development of Pathogenic CD11b+CD4+ T Cells in the CNS during Progressive EAE.
Severe disease reactivation in four patients with relapsing-remitting multiple sclerosis after fingolimod cessation.
HyperCKemia Related to the Initial and Recurrent Attacks of Neuromyelitis Optica.
Conference Report: Multiple Sclerosis Update: Hot topics from 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS/ACTRIMS).
[Epstein-Barr virus in the pathogenesis of multiple sclerosis (a review).]
Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology.
Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave Dreams Study (Brain Venous Drainage Exploited Against Multiple Sclerosis): study protocol for a randomized controlled trial.
Sleep-disordered breathing in multiple sclerosis.
IgM antibody identifies good candidates for natalizumab
Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses.
The effect of an AFO-shaped elastic band on drop-foot gait in patients with central neurological lesions.
Solitary sclerosis: progressive myelopathy from solitary demyelinating lesion. A new entity?
Evaluation of a new approach for semi-automatic segmentation of the cerebellum in patients with multiple sclerosis.
Keeping cool: use of air conditioning by australians with multiple sclerosis.
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis.
Fingolimod for the Treatment of Intracerebral Hemorrhage: A 2-Arm Proof-of-Concept Study.
Pages
« first
‹ previous
…
149
150
151
152
153
154
155
156
157
…
next ›
last »